Respiratory Syncytial Virus (RSV) | RSV | CDC
Respiratory syncytial virus (RSV) usually causes mild, cold-like symptoms in most people, but it is the leading cause of infant hospitalization in the U.S.
About RSV | RSV | CDC - Centers for Disease Control and Prevention
Jun 5, 2024 · What is RSV? Respiratory syncytial (sin-SISH-uhl) virus, or RSV, is a common respiratory virus that infects the lungs, but can also affect the nose and throat. RSV spreads in the fall and winter along with other respiratory viruses, like flu and COVID-19. It usually peaks in December and January.
Clinical Overview of RSV | RSV | CDC
Jul 3, 2024 · RSV usually causes mild symptoms, but can cause severe illness in infants, some young children, and older adults. CDC recommends a single dose of RSV vaccine to protect all adults ages 75 and older and adults ages 60-74 who are at increased risk of severe RSV.
RSV (Respiratory Syncytial Virus) Immunizations | CDC
Respiratory syncytial (sin-SISH-uhl) virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious. Infants and older adults are more likely to develop severe RSV and need hospitalization.
Symptoms of RSV | RSV | CDC - Centers for Disease Control and …
Jun 5, 2024 · RSV usually causes mild, cold-like symptoms. Most RSV infections go away on their own. RSV can be serious for babies, some young children, and older adults. There is no treatment for RSV, but you can manage symptoms with over-the-counter medications.
RSV Vaccine Information Statement | CDC
Oct 19, 2023 · RSV vaccine can prevent lower respiratory tract disease caused by respiratory syncytial virus (RSV). RSV is a common respiratory virus that usually causes mild, cold-like symptoms. RSV can cause illness in people of all ages but may be especially serious for infants and older adults.
RSV in Infants and Young Children | RSV | CDC
Jun 5, 2024 · Each year in the United States, an estimated 58,000-80,000 children younger than 5 years are hospitalized due to RSV infection. Children at greatest risk for severe illness from RSV include the following: Premature infants. Infants up to 12 months, especially those 6 …
Vaccines by Age | Vaccines & Immunizations | CDC
Aug 14, 2024 · Respiratory syncytial virus (RSV) vaccine. 1 Dose. ... CDC recommends COVID-19 vaccination for everyone aged 6 months and older. DTaP vaccine. 3 rd dose of 5. A DTaP vaccine is the best protection from three serious diseases: diphtheria, tetanus, and whooping cough (pertussis). All three of these diseases can be deadly for people of any age ...
In June 2023, CDC’s Advisory Committee on Immunization Practices (ACIP) recommended the first two RSV vaccines for older adults. RSVPreF3 (Arexvy, GSK) is a 1-dose adjuvanted (AS01E) recombinant prefusion F protein (preF) vaccine. RSVpreF (Abrysvo, Pfizer) is a 1-dose recombinant preF vaccine.
Information on Respiratory Syncytial Virus (RSV) Vaccine ... - CDC
Jan 22, 2024 · In August and September 2023, CDC and the Advisory Committee on Immunization Practices recommended two RSV prevention products to prevent RSV-associated lower respiratory tract disease in infants. Nirsevimab (Beyfortus, Sanofi, and AstraZeneca) is only recommended for infants and some young children at increased risk for severe RSV disease.
- Some results have been removed
Skip to content